dc.creator | Bibak B. | |
dc.creator | Shakeri F. | |
dc.creator | Barreto G.E. | |
dc.creator | Keshavarzi Z. | |
dc.creator | Sathyapalan T. | |
dc.creator | Sahebkar A. | |
dc.date.accessioned | 2020-09-02T22:13:10Z | |
dc.date.accessioned | 2022-11-08T20:28:08Z | |
dc.date.available | 2020-09-02T22:13:10Z | |
dc.date.available | 2022-11-08T20:28:08Z | |
dc.date.created | 2020-09-02T22:13:10Z | |
dc.date.issued | 2019 | |
dc.identifier | 45, 6, 867-879 | |
dc.identifier | 09516433 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3758 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146711 | |
dc.language | en | |
dc.publisher | Blackwell Publishing Inc. | |
dc.subject | auraptene | |
dc.subject | chemopreventive | |
dc.subject | pharmacological properties | |
dc.subject | auraptene | |
dc.subject | cisplatin | |
dc.subject | fluorouracil | |
dc.subject | nifedipine | |
dc.subject | paclitaxel | |
dc.subject | antiinflammatory agent | |
dc.subject | auraptene | |
dc.subject | coumarin | |
dc.subject | coumarin derivative | |
dc.subject | aberrant crypt focus | |
dc.subject | Aegle marmelos | |
dc.subject | antidiabetic activity | |
dc.subject | antihypertensive activity | |
dc.subject | antiinflammatory activity | |
dc.subject | antineoplastic activity | |
dc.subject | antioxidant activity | |
dc.subject | apoptosis | |
dc.subject | cardiovascular system | |
dc.subject | cell growth | |
dc.subject | cell viability | |
dc.subject | cholestasis | |
dc.subject | data base | |
dc.subject | drug cytotoxicity | |
dc.subject | drug effect | |
dc.subject | drug efficacy | |
dc.subject | drug potentiation | |
dc.subject | drug safety | |
dc.subject | dysentery | |
dc.subject | G2 phase cell cycle checkpoint | |
dc.subject | gastrointestinal tract | |
dc.subject | human | |
dc.subject | immune system | |
dc.subject | inflammatory disease | |
dc.subject | intracellular signaling | |
dc.subject | liver injury | |
dc.subject | malignant neoplasm | |
dc.subject | Medline | |
dc.subject | mild cognitive impairment | |
dc.subject | nervous system | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | pain | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | Rutaceae | |
dc.subject | scar | |
dc.subject | Scopus | |
dc.subject | sour orange | |
dc.subject | Web of Science | |
dc.subject | wound | |
dc.subject | Aegle | |
dc.subject | cell proliferation | |
dc.subject | chemistry | |
dc.subject | Citrus | |
dc.subject | inflammation | |
dc.subject | signal transduction | |
dc.subject | Aegle | |
dc.subject | Anti-Inflammatory Agents | |
dc.subject | Apoptosis | |
dc.subject | Cell Proliferation | |
dc.subject | Citrus | |
dc.subject | Coumarins | |
dc.subject | Humans | |
dc.subject | Inflammation | |
dc.subject | Signal Transduction | |
dc.title | A review of the pharmacological and therapeutic effects of auraptene | |
dc.type | Review | |